Rodrigo O Moreira

5PUBLICATIONS
45CO-AUTHORS
Sport and exercise nutritionPublic health nutritionGene and molecular therapyClinical pharmacology and therapeuticsMedical biochemistry - lipids
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 11, 2025
2025 Brazilian Evidence-based Guideline on the Management of Obesity and Prevention of Cardiovascular Disease and Obesity-Associated Complications: A Position Statement by Five Medical Societies.

José Francisco Kerr Saraiva, Cynthia M Valerio, Fabiana H Rached

|Nov 06, 2025
Cost of Metabolic Dysfunction-Associated Steatotic Liver Disease Screening Among All People Living With Diabetes in Six Countries.

Jeffrey V Lazarus, Leire Agirre-Garrido, J Emilio Miralles-Sanchez

|Nov 01, 2025
ADD2Dia: Real-World Clinical Effectiveness of Adding a Sodium-Glucose Cotransporter 2 Inhibitor to Gliclazide-Based Therapy in Type 2 Diabetes.

Rodrigo O Moreira, Nemencio A Nicodemus, Abdurrahman Comlekci

|Dec 12, 2024
Pharmacologic Treatment of Obesity in adults and its impact on comorbidities: 2024 Update and Position Statement of Specialists from the Brazilian Association for the Study of Obesity and Metabolic Syndrome (Abeso) and the Brazilian Society of Endocrinology and Metabolism (SBEM).

Rodrigo O Moreira, Cynthia M Valerio, Alexandre Hohl

|Oct 18, 2024
Response to the letter to the editor Fibrosis or steatosis: which is the best screening target? Comment on the Brazilian evidence-based guideline for screening, diagnosis, treatment, and follow-up of metabolic dysfunction-associated steatotic liver disease (MASLD) in adult individuals with overweight or obesity.

Rodrigo O Moreira

Pageof 1

Frequent Collaborators

2 joint publications

Cynthia M Valerio

2 joint publications

Fábio R Trujilho

2 joint publications

Bruno Halpern

2 joint publications

Marcio C Mancini